Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2016, Article ID 1973413, 8 pages
http://dx.doi.org/10.1155/2016/1973413
Research Article

A Tobacco-Derived Thymosin β4 Concatemer Promotes Cell Proliferation and Wound Healing in Mice

1Joint Tomato Research Institute, School of Agriculture and Biology, Shanghai Jiao Tong University, Shanghai 200240, China
2Plant Biotechnology Research Center, School of Agriculture and Biology, Shanghai Jiao Tong University, Shanghai 200240, China

Received 2 April 2016; Accepted 14 June 2016

Academic Editor: Hafiz M. N. Iqbal

Copyright © 2016 Rylosona Janarthini et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. T. L. K. Low, S. K. Hu, and A. L. Goldstein, “Complete amino acid sequence of bovine thymosin β4: a thymic hormone that induces terminal deoxynucleotidyl transferase activity in thymocyte populations,” Proceedings of the National Academy of Sciences of the United States of America, vol. 78, no. 2, pp. 1162–1166, 1981. View at Publisher · View at Google Scholar · View at Scopus
  2. A. L. Goldstein and H. K. Kleinman, “Advances in the basic and clinical applications of thymosin β4,” Expert Opinion on Biological Therapy, vol. 15, supplement 1, pp. s139–s145, 2015. View at Google Scholar
  3. E. Irobi, A. H. Aguda, M. Larsson et al., “Structural basis of actin sequestration by thymosin-β4: Implications for WH2 proteins,” The EMBO Journal, vol. 23, no. 18, pp. 3599–3608, 2004. View at Publisher · View at Google Scholar · View at Scopus
  4. A. L. Goldstein, E. Hannappel, and H. K. Kleinman, “Thymosin β4: actin-sequestering protein moonlights to repair injured tissues,” Trends in Molecular Medicine, vol. 11, no. 9, pp. 421–429, 2005. View at Publisher · View at Google Scholar · View at Scopus
  5. J. Knop, C. App, T. Huff, F. Iavarone, M. Castagnola, and E. Hannappel, “Identification of PDGF-BB binding to thymosin β4 by chemical cross-linking,” Expert Opinion on Biological Therapy, vol. 15, supplement 1, pp. S147–S154, 2015. View at Google Scholar
  6. N. Kumar, P. Nakagawa, B. Janic et al., “The anti-inflammatory peptide Ac-SDKP is released from thymosin-β4 by renal meprin-α and prolyl oligopeptidase,” American Journal of Physiology—Renal Physiology, vol. 310, no. 10, pp. F1026–F1034, 2016. View at Publisher · View at Google Scholar
  7. K. Matsuo, Y. Akasaki, K. Adachi et al., “Promoting effects of thymosin β4 on granulation tissue and new bone formation after tooth extraction in rats,” Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology, vol. 114, no. 1, pp. 17–26, 2012. View at Publisher · View at Google Scholar · View at Scopus
  8. N. Smart, A. Rossdeutsch, and P. R. Riley, “Thymosin β4 and angiogenesis: modes of action and therapeutic potential,” Angiogenesis, vol. 10, no. 4, pp. 229–241, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. I. Bock-Marquette, A. Saxena, M. D. White, J. M. DiMaio, and D. Srivastava, “Thymosin β4 activates integrin-linked kinase and promotes cardiac cell migration, survival and cardiac repair,” Nature, vol. 432, no. 7016, pp. 466–472, 2004. View at Publisher · View at Google Scholar · View at Scopus
  10. G. Sosne and H. K. Kleinman, “Primary mechanisms of thymosin β4 repair activity in dry eye disorders and other tissue injuries,” Investigative Ophthalmology & Visual Science, vol. 56, no. 9, pp. 5110–5117, 2015. View at Publisher · View at Google Scholar · View at Scopus
  11. Y. Zuo, B. Chun, S. A. Potthoff et al., “Thymosin β4 and its degradation product, Ac-SDKP, are novel reparative factors in renal fibrosis,” Kidney International, vol. 84, no. 6, pp. 1166–1175, 2013. View at Publisher · View at Google Scholar · View at Scopus
  12. E. Conte, M. Iemmolo, M. Fruciano et al., “Effects of thymosin β4 and its N-terminal fragment Ac-SDKP on TGF-β-treated human lung fibroblasts and in the mouse model of bleomycin-induced lung fibrosis,” Expert Opinion on Biological Therapy, vol. 15, supplement 1, pp. 211–221, 2015. View at Publisher · View at Google Scholar
  13. K. M. Malinda, G. S. Sidhu, H. Mani et al., “Thymosin β4 accelerates wound healing,” Journal of Investigative Dermatology, vol. 113, no. 3, pp. 364–368, 1999. View at Publisher · View at Google Scholar · View at Scopus
  14. H.-J. Cha, M.-J. Jeong, and H. K. Kleinman, “Role of thymosin β4 in tumor metastasis and angiogenesis,” Journal of the National Cancer Institute, vol. 95, no. 22, pp. 1674–1680, 2003. View at Publisher · View at Google Scholar · View at Scopus
  15. J. Caers, E. Otjacques, D. Hose, B. Klein, and K. Vanderkerken, “Thymosin β4 in multiple myeloma: friend or foe,” Annals of the New York Academy of Sciences, vol. 1194, pp. 125–129, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. B. Can, F. Karagoz, L. Yildiz et al., “Thymosin β4 is a novel potential prognostic marker in gastrointestinal stromal tumors,” Acta Pathologica, Microbiologica et Immunologica Scandinavica, vol. 120, no. 9, pp. 689–698, 2012. View at Publisher · View at Google Scholar · View at Scopus
  17. J. Marx, “Thymosins: clinical promise after a decades-long search,” Science, vol. 316, no. 5825, pp. 682–683, 2007. View at Publisher · View at Google Scholar · View at Scopus
  18. L. Wang, M. Chopp, L. Jia et al., “Therapeutic benefit of extended thymosin β4 treatment is independent of blood glucose level in mice with diabetic peripheral neuropathy,” Journal of Diabetes Research, vol. 2015, Article ID 173656, 13 pages, 2015. View at Publisher · View at Google Scholar · View at Scopus
  19. G. Sosne, E. A. Szliter, R. Barrett, K. A. Kernacki, H. Kleinman, and L. D. Hazlett, “Thymosin beta 4 promotes corneal wound healing and decreases inflammation in vivo following alkali injury,” Experimental Eye Research, vol. 74, no. 2, pp. 293–299, 2002. View at Publisher · View at Google Scholar · View at Scopus
  20. G. Sosne, P. Qiu, M. Kurpakus-Wheater, and H. Matthew, “Thymosin β4 and corneal wound healing: visions of the future,” Annals of the New York Academy of Sciences, vol. 1194, pp. 190–198, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. R. Hinkel, C. El-Aouni, T. Olson et al., “Thymosin β4 is an essential paracrine factor of embryonic endothelial progenitor cell-mediated cardioprotection,” Circulation, vol. 117, no. 17, pp. 2232–2240, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. C. Wei, S. Kumar, I.-K. Kim, and S. Gupta, “Thymosin beta 4 protects cardiomyocytes from oxidative stress by targeting anti-oxidative enzymes and anti-apoptotic genes,” PLoS ONE, vol. 7, no. 8, article e42586, 2012. View at Publisher · View at Google Scholar · View at Scopus
  23. E. Vasilopoulou, P. J. D. Winyard, P. R. Riley, and D. A. Long, “The role of thymosin-β4 in kidney disease,” Expert Opinion on Biological Therapy, vol. 15, supplement 1, pp. S187–S190, 2015. View at Publisher · View at Google Scholar
  24. X. Wang, G. Yang, S. Li, M. Gao, P. Zhao, and L. Zhao, “The Escherichia coli-derived thymosin β4 concatemer promotes cell proliferation and healing wound in mice,” BioMed Research International, vol. 2013, Article ID 241721, 7 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  25. X. Li, L. Zheng, F. Peng et al., “Recombinant thymosin beta 4 can promote full-thickness cutaneous wound healing,” Protein Expression and Purification, vol. 56, no. 2, pp. 229–236, 2007. View at Publisher · View at Google Scholar · View at Scopus
  26. R. K. Jhinjer, l. Verma, S. H. Wani, and S. S. Gosal, “Molecular farming using transgenic approaches,” in Advances in Plant Breeding Strategies: Agronomic, Abiotic and Biotic Stress Traits, J. M. Al-Khayri, S. M. Jain, and D. V. Johnson, Eds., pp. 97–145, Springer, New York, NY, USA, 2016. View at Publisher · View at Google Scholar
  27. J. K.-C. Ma, P. M. W. Drake, and P. Christou, “The production of recombinant pharmaceutical proteins in plants,” Nature Reviews Genetics, vol. 4, no. 10, pp. 794–805, 2003. View at Publisher · View at Google Scholar · View at Scopus
  28. G. Walsh, “Biopharmaceutical benchmarks 2010,” Nature Biotechnology, vol. 28, no. 9, pp. 917–924, 2010. View at Publisher · View at Google Scholar · View at Scopus
  29. G. Jyothishwaran, D. Kotresha, T. Selvaraj, S. M. Srideshikan, P. K. Rajvanshi, and C. Jayabaskaran, “A modified freeze-thaw method for efficient transformation of Agrobacterium tumefaciens,” Current Science, vol. 93, no. 6, pp. 770–772, 2007. View at Google Scholar · View at Scopus
  30. L. J. Cui, H. Z. Peng, R. Zhang, Y. H. Chen, L. X. Zhao, and K. X. Tang, “Recombinant hHscFv–RC-RNase protein derived from transgenic tobacco acts as a bifunctional molecular complex against hepatocellular carcinoma,” Biotechnology and Applied Biochemistry, vol. 59, no. 5, pp. 323–329, 2012. View at Publisher · View at Google Scholar · View at Scopus
  31. M. M. Bradford, “A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding,” Analytical Biochemistry, vol. 72, no. 1-2, pp. 248–254, 1976. View at Publisher · View at Google Scholar · View at Scopus
  32. Y. Chen, A. Wang, L. Zhao, G. Shen, L. Cui, and K. Tang, “Expression of thymosin α1 concatemer in transgenic tomato (Solanum lycopersicum) fruits,” Biotechnology and Applied Biochemistry, vol. 52, no. 4, pp. 303–312, 2009. View at Publisher · View at Google Scholar · View at Scopus
  33. T. Mosmann, “Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays,” Journal of Immunological Methods, vol. 65, no. 1-2, pp. 55–63, 1983. View at Publisher · View at Google Scholar · View at Scopus
  34. A. J. M. Matzke and M. A. Matzke, “Position effects and epigenetic silencing of plant transgenes,” Current Opinion in Plant Biology, vol. 1, no. 2, pp. 142–148, 1998. View at Publisher · View at Google Scholar · View at Scopus
  35. Q. Que, H.-Y. Wang, J. J. English, and R. A. Jorgensen, “The frequency and degree of cosuppression by sense chalcone synthase transgenes are dependent on transgene promoter strength and are reduced by premature nonsense codons in the transgene coding sequence,” Plant Cell, vol. 9, no. 8, pp. 1357–1368, 1997. View at Publisher · View at Google Scholar · View at Scopus
  36. L. F. Maxfield, C. D. Fraize, and J. M. Coffin, “Relationship between retroviral DNA-integration-site selection and host cell transcription,” Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 5, pp. 1436–1441, 2005. View at Publisher · View at Google Scholar · View at Scopus
  37. S.-W. Wang, A. L. Stevenson, S. E. Kearsey, S. Watt, and J. Bähler, “Global role for polyadenylation-assisted nuclear RNA degradation in posttranscriptional gene silencing,” Molecular and Cellular Biology, vol. 28, no. 2, pp. 656–665, 2008. View at Publisher · View at Google Scholar · View at Scopus
  38. D. Safer, M. Elzinga, and V. T. Nachmias, “Thymosin β4 and Fx, an actin-sequestering peptide, are indistinguishable,” The Journal of Biological Chemistry, vol. 266, no. 7, pp. 4029–4032, 1991. View at Google Scholar · View at Scopus
  39. H.-S. Moon, S. Even-Ram, H. K. Kleinman, and H.-J. Cha, “Zyxin is upregulated in the nucleus by thymosin β4 in SiHa cells,” Experimental Cell Research, vol. 312, no. 17, pp. 3425–3431, 2006. View at Publisher · View at Google Scholar · View at Scopus
  40. B. Xue, A. H. Aguda, and R. C. Robinson, “Models of the actin-bound forms of the β-thymosins,” Annals of the New York Academy of Sciences, vol. 1112, pp. 56–66, 2007. View at Publisher · View at Google Scholar · View at Scopus